Abstract
The mechanism of captopril, an angiotensin converting enzyme (ACE) inhibitor with sulfhydryl group (SH) in its structure, to produce an endothelium-dependent vasorelaxation was studied. In rabbit aorta with intact endothelium and precontracted with phenylephrine, captopril and superoxide dismutase (SOD) produced dose-dependent relaxation. Lisinopril, an ACE inhibitor without a -SH group in its structure, did not produce endothelium-dependent relaxation. It was observed that captopril, like SOD, produced the relaxation by protecting the EDRF from getting inactivated by superoxide anions as pyrogallol and methylene blue inhibited both the captopril and SOD-mediated relaxation. The free radical scavenging action of captopril is further substantiated by the observation that captopril, but not lisinopril, inhibited FeCl3/ascorbic acid-induced lipid peroxidation in whole tissue homogenates of rabbit aorta to a level comparable to that of SOD. These results suggest that endothelium-dependent vasodilation produced by captopril may be due to its ability to scavenge superoxide anion and this property may be ascribed to the -SH group present in its structure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Marks ES, Bing RF, Thurston H, Swales JD: Vasodepressor property of the converting enzyme inhibitor captopril (SQ-14, 255). The role of factors other than renin-angiotensin blockade in the rat. Clin Sci 58: 1–6, 1980
Antonaccio MP, Rubin B, Kotler D: Effects of captopril on vascular reactivity of SHR in vivo and in vitro. Hypertension 3 (suppl II): H211–H215, 1981
Tang SS, Stevenson L, Dzau VJ: Endothelial renin-angiotensin pathway. Circ Res 66: 103–108, 1991
Van Iwaarden F, de Groot PG, Sixma JJ, Berrettini M, Bouma BN: High molecular weight kininogen is present in cultured endothelial cells: Localization, isolation and characterization. Blood 71: 1268–1276, 1981
Mombouli JV, Vanhoutte PM: Kinins and endothelium-dependent relaxation to converting enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharmacol 18: 926–927, 1991
Moroi M, Akatsuka N, Fukazawa M, Hara K, Ishikawa M, Alikawa J, Namiki A, Yamaguchi T: Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries. Am J Physiol 266: H583–H589, 1994
Wiemer G, Schoekens BA, Becker RHA, Busse R: Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18: 558–563, 1991
Van Gilst WH, de Graeff PA, de Leeuw MJ, Scholtens E, Wesseling H: Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo – and endogenous nitrovasodilators. J Cardiovasc Pharmacol 18: 429–436, 1991
Goldschmidt JE, Tallarida RJ: Pharmacological evidence that captopril possesses and endothelium-mediated component of vasodilation: Effect of sulfhydryl groups on endothelium derived relaxing factor. J Pharmacol Exp Ther 257: 1136–1145, 1991
Bagchi D, Parsad R, Das DK: Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun 158: 52–57, 1989
Pi X-J, Chen X: Captopril and ramiprilat protect against free radical injury in isolated working rat heart. J Mol Cell Cardiol 21: 1261–1271, 1989
Chopra M, Scott N, Mcmurray J, McFay J, Bridges A, Smith WE Belch JJF: Captopril: A free radical scavenger. Br J Clin Pharmacol 27: 396–399, 1992
Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G: Pharmacological evidence that endothelium-derived relaxing factor is NO: Use of pyrogallol and superoxide dismutase to study endotheliumdependent and NO-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244: 181–188, 1988
Sim MK, Singh M: Decreased responsiveness of the aortae of hypertensive rat to acetylcholine, histamine and nor-adrenaline. Br J Pharmacol 90: 147–150, 1988
Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacabson EJ, McCall JM: Novel 21-aminosteroids as potent inhibitors of irondependent lipid peroxidation. J Biol Chem 262: 10438–10440, 1987
Collis MG, Keddie JR: Captopril attenuates adrenergic vasoconstriction in rat mesenteric by angiotensin-dependent and independent mechanisms. Clin Sci 61: 281–286, 1981
Chiba S, Quilley CP, Quilley J, McGiff JC: Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney. Eur J Pharmacol 83: 243–252, 1989
Gillis NC, Chen X, Merker MM: Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury. J Pharmacol Exp Ther 262: 212–216, 1992
Auch-Schwelk W, Katusic ZS, Vanhoutte PM: Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension 19: 442–445, 1993
Schneck KA, Hess JF, Stonesifer GY, Ransom RW: Bradykinin B1-receptors in rabbit aorta smooth muscle cells in culture. Eur J Pharmacol 266: 277–282, 1994
Marczin N, Ryan VS, Catravas JD: Methylene blue inhibits nitrovasodilator and endothelium-derived relaxing factor induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 263: 170–179, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mittra, S., Singh, M. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Mol Cell Biochem 183, 63–67 (1998). https://doi.org/10.1023/A:1006854313163
Issue Date:
DOI: https://doi.org/10.1023/A:1006854313163